Trials / Completed
CompletedNCT00194272
Two-Dose Methotrexate for Ectopic Pregnancy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- University of Pennsylvania · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study examines the safety and acceptability of a novel "two dose" regimen of methotrexate to treat ectopic pregnancy.
Detailed description
The regimen is an attempt to create a middle ground between the 2 commonly used regimens - "single dose" and "multi dose". The "multi dose" regimen is more effective, but the "single dose" regimen is more convenient for patients and has fewer side effects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Methotrexate | Two dose methotrexate |
Timeline
- Start date
- 2001-03-01
- Completion
- 2007-06-01
- First posted
- 2005-09-19
- Last updated
- 2011-08-09
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00194272. Inclusion in this directory is not an endorsement.